Clinical Trials Browser

INDUSTRY × Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation × adavosertib × Clear all

NCT02272790 2023-10-03

Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

95 enrolled 61 charts

Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation